Bill115th CongressFiled May 23, 2018Health
H.R. 5926
Naloxone Guidelines Act of 2018
Bill journey · stage 2 of 5
Under committee review
FiledFiled
CommitteeComm.
PassedFloor
Both ChambersBoth
Became LawLaw
What it doesSummary introduced in house (May 23, 2018)
Naloxone Guidelines Act of 2018
This bill requires the Department of Health and Human Services to issue guidelines for prescribing an opioid overdose reversal drug (e.g., naloxone).
The guidelines must address issues relating to the distribution, education, and safety of opioid overdose reversal drugs, including:
- co-prescription with an opioid;
- safe dosages;
- prescription for non-patients; and
- standing orders (i.e., orders that allow dispensing without a prescription).
What just happenedMay 23, 2018
Referred to the House Committee on Energy and Commerce.
Who’s behind it
Rep. Keating, William R. [D-MA-9](D-MA)Sponsor
1 cosponsor1 R
1cosponsors1committees3actions1related bills5subjects
- Introduced in HouseMay 23, 2018
- May 23, 2018IntroReferralH11100
Referred to the House Committee on Energy and Commerce.
Energy and Commerce Committee - May 23, 2018IntroReferralIntro-H
Introduced in House
- May 23, 2018IntroReferral1000
Introduced in House